231 related articles for article (PubMed ID: 8616888)
1. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.
Li L; Cohen SN
Cell; 1996 May; 85(3):319-29. PubMed ID: 8616888
[TBL] [Abstract][Full Text] [Related]
2. Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein.
Liu K; Li L; Nisson PE; Gruber C; Jessee J; Cohen SN
Mol Cell Biol; 1999 May; 19(5):3696-703. PubMed ID: 10207093
[TBL] [Abstract][Full Text] [Related]
3. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer.
Li L; Li X; Francke U; Cohen SN
Cell; 1997 Jan; 88(1):143-54. PubMed ID: 9019400
[TBL] [Abstract][Full Text] [Related]
4. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
[TBL] [Abstract][Full Text] [Related]
5. Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis.
Liu K; Li L; Cohen SN
J Biol Chem; 2000 Oct; 275(40):31093-8. PubMed ID: 10906334
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of aberrant TSG101 transcripts in acute myeloblastic leukemia.
Lin SF; Lin PM; Liu TC; Chang JG; Sue YC; Chen TP
Leuk Lymphoma; 2000 Feb; 36(5-6):463-6. PubMed ID: 10784390
[TBL] [Abstract][Full Text] [Related]
7. Analysis of expression and structure of the TSG101 gene in cervical cancer cells.
Broniarczyk J; Olejnik-Schmidt AK; Luczak MW; Schmidt MT; Dabrowski M; Józefiak A; Kedzia W; Kwasniewska A; Gozdzicka-Józefiak A
Int J Mol Med; 2010 May; 25(5):777-83. PubMed ID: 20372822
[TBL] [Abstract][Full Text] [Related]
8. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains.
Maucuer A; Camonis JH; Sobel A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3100-4. PubMed ID: 7724523
[TBL] [Abstract][Full Text] [Related]
9. Frequent abnormalities of TSG101 transcripts in human prostate cancer.
Sun Z; Pan J; Bubley G; Balk SP
Oncogene; 1997 Dec; 15(25):3121-5. PubMed ID: 9444960
[TBL] [Abstract][Full Text] [Related]
10. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
11. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
Hosokawa Y; Nagai E; Seto M
J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
[TBL] [Abstract][Full Text] [Related]
12. TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer.
Liu F; Yu Y; Jin Y; Fu S
Mol Biol Rep; 2010 Jul; 37(6):2829-38. PubMed ID: 19787439
[TBL] [Abstract][Full Text] [Related]
13. TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
Chua HH; Huang CS; Weng PL; Yeh TH
Oncotarget; 2016 Feb; 7(7):8240-52. PubMed ID: 26811492
[TBL] [Abstract][Full Text] [Related]
14. Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues.
Wagner KU; Krempler A; Qi Y; Park K; Henry MD; Triplett AA; Riedlinger G; Rucker III EB; Hennighausen L
Mol Cell Biol; 2003 Jan; 23(1):150-62. PubMed ID: 12482969
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
16. Molecular diversity of the SCG10/stathmin gene family in the mouse.
Okazaki T; Yoshida BN; Avraham KB; Wang H; Wuenschell CW; Jenkins NA; Copeland NG; Anderson DJ; Mori N
Genomics; 1993 Nov; 18(2):360-73. PubMed ID: 8288240
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic.
Hromas R; Morris J; Cornetta K; Berebitsky D; Davidson A; Sha M; Sledge G; Rauscher F
Cancer Res; 1995 Aug; 55(16):3610-4. PubMed ID: 7627970
[TBL] [Abstract][Full Text] [Related]
18. Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation.
Beauparlant P; Kwan I; Bitar R; Chou P; Koromilas AE; Sonenberg N; Hiscott J
Oncogene; 1994 Nov; 9(11):3189-97. PubMed ID: 7936641
[TBL] [Abstract][Full Text] [Related]
19. Stathmin gene family: phylogenetic conservation and developmental regulation in Xenopus.
Maucuer A; Moreau J; Méchali M; Sobel A
J Biol Chem; 1993 Aug; 268(22):16420-9. PubMed ID: 8344928
[TBL] [Abstract][Full Text] [Related]
20. The stathmin family -- molecular and biological characterization of novel mammalian proteins expressed in the nervous system.
Ozon S; Maucuer A; Sobel A
Eur J Biochem; 1997 Sep; 248(3):794-806. PubMed ID: 9342231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
